These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28824048)

  • 21. Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
    Nishi T; Piroth Z; De Bruyne B; Jagic N; Möbius-Winkler S; Kobayashi Y; Derimay F; Fournier S; Barbato E; Tonino P; Jüni P; Pijls NHJ; Fearon WF
    Circulation; 2018 Oct; 138(17):1797-1804. PubMed ID: 30354650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of impaired fractional flow reserve after coronary interventions on outcomes: a systematic review and meta-analysis.
    Wolfrum M; Fahrni G; de Maria GL; Knapp G; Curzen N; Kharbanda RK; Fröhlich GM; Banning AP
    BMC Cardiovasc Disord; 2016 Sep; 16(1):177. PubMed ID: 27608682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and physiological outcomes of fractional flow reserve-guided percutaneous coronary intervention in patients with serial stenoses within one coronary artery.
    Kim HL; Koo BK; Nam CW; Doh JH; Kim JH; Yang HM; Park KW; Lee HY; Kang HJ; Cho YS; Youn TJ; Kim SH; Chae IH; Choi DJ; Kim HS; Oh BH; Park YB
    JACC Cardiovasc Interv; 2012 Oct; 5(10):1013-8. PubMed ID: 23078728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent.
    Ito T; Fujita H; Tani T; Ohte N
    Atherosclerosis; 2015 Apr; 239(2):311-7. PubMed ID: 25682029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease.
    Takamiya Y; Miura S; Kawamura A; Tanigawa H; Zhang B; Iwata A; Nishikawa H; Matsuo K; Shirai K; Saku K
    Coron Artery Dis; 2009 Jun; 20(4):288-94. PubMed ID: 19440067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.
    Völz S; Dworeck C; Redfors B; Pétursson P; Angerås O; Gan LM; Götberg M; Sarno G; Venetsanos D; Grimfärd P; Hofmann R; Jensen J; Björklund F; Danielewicz M; Linder R; Råmunddal T; Fröbert O; Witt N; James S; Erlinge D; Omerovic E
    J Am Coll Cardiol; 2020 Jun; 75(22):2785-2799. PubMed ID: 32498806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina.
    Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
    Circ J; 2020 Sep; 84(10):1837-1845. PubMed ID: 32863287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial Fractional Flow Reserve Measurements Post Coronary Chronic Total Occlusion Percutaneous Coronary Intervention.
    Karamasis GV; Kalogeropoulos AS; Mohdnazri SR; Al-Janabi F; Jones R; Jagathesan R; Aggarwal RK; Clesham GJ; Tang KH; Kelly PA; Davies JR; Werner GS; Keeble TR
    Circ Cardiovasc Interv; 2018 Nov; 11(11):e006941. PubMed ID: 30571203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of coronary pressure measurement for functional evaluation of drug-eluting stent restenosis.
    Nam CW; Rha SW; Koo BK; Doh JH; Chung WY; Yoon MH; Tahk SJ; Lee BK; Lee JB; Yoo KD; Cho YK; Chung IS; Hur SH; Kim KB; Choi CU; Oh DJ
    Am J Cardiol; 2011 Jun; 107(12):1783-6. PubMed ID: 21481824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CT-based total vessel plaque analyses improves prediction of hemodynamic significance lesions as assessed by fractional flow reserve in patients with stable angina pectoris.
    Øvrehus KA; Gaur S; Leipsic J; Jensen JM; Dey D; Bøtker HE; Ahmadi A; Achenbach S; Ko B; Nørgaard BL
    J Cardiovasc Comput Tomogr; 2018; 12(4):344-349. PubMed ID: 29866619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Murai T; Kanaji Y; Yonetsu T; Lee T; Matsuda J; Usui E; Araki M; Niida T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):233-242. PubMed ID: 27219714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of microvascular resistance on fractional flow reserve after successful percutaneous coronary intervention.
    Murai T; Lee T; Yonetsu T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):585-92. PubMed ID: 24678006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
    Ishibashi Y; Muramatsu T; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Cho YK; Garcia-Garcia HM; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; McClean D; de Sousa Almeida M; Wasungu L; Miquel-Hebert K; Dudek D; Chevalier B; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.
    Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):269-77. PubMed ID: 25345751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Value of Pre- and Post-Stenting Fractional Flow Reserve for Predicting Mid-Term Stent Restenosis Following Percutaneous Coronary Intervention (PCI).
    Rai A; Bahremand M; Saidi MR; Jalili Z; Salehi N; Assareh M; Abarghoei GA; Kazerani H
    Glob J Health Sci; 2015 Dec; 8(7):240-44. PubMed ID: 26925913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.
    Puymirat E; Peace A; Mangiacapra F; Conte M; Ntarladimas Y; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Circ Cardiovasc Interv; 2012 Feb; 5(1):62-8. PubMed ID: 22319067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
    Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.